High Tower Advisors, LLC Nephros Inc Transaction History
High Tower Advisors, LLC
- $64.2 Billion
- Q2 2024
A detailed history of High Tower Advisors, LLC transactions in Nephros Inc stock. As of the latest transaction made, High Tower Advisors, LLC holds 57,210 shares of NEPH stock, worth $99,545. This represents 0.0% of its overall portfolio holdings.
Number of Shares
57,210
Previous 58,210
1.72%
Holding current value
$99,545
Previous $127,000
5.51%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding NEPH
# of Institutions
19Shares Held
4.32MCall Options Held
0Put Options Held
0-
Wexford Capital LP Greenwich, CT3.6MShares$6.26 Million2.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA194KShares$337,6010.0% of portfolio
-
Bard Associates Inc Chicago, IL176KShares$305,5370.15% of portfolio
-
Geode Capital Management, LLC Boston, MA78KShares$135,7800.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny41KShares$71,3400.0% of portfolio
About NEPHROS INC
- Ticker NEPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 10,318,800
- Market Cap $18M
- Description
- Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water ...